Trials / Completed
CompletedNCT02125279
Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 mo of Age) With Mild to Moderate Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 2 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to treat pediatric subjects (2 to 16 years and 11 months of age) with mild to moderate plaque psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcitriol |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2014-04-29
- Last updated
- 2021-02-18
- Results posted
- 2019-11-29
Locations
16 sites across 5 countries: United States, Belgium, Canada, Germany, Italy
Source: ClinicalTrials.gov record NCT02125279. Inclusion in this directory is not an endorsement.